Promethean Share Discussion Threads

[marktw] 12/12/2002 16:56

Yeah... gimmee my money back you bastuds!

[isis] 12/12/2002 16:50

I agree it is pointless to keep running these cash burners just to keep (usually highly paid) jobs.
This is not how a capitalist economy works & everybody losses in the end - especially shareholders whoi provided the money in the first place!

[pdyke14856] 12/12/2002 16:28

Having looked into this yesterday I have to agree that there is definitely more upside to this share. It is undervalued and Paul Scott is making exactly the point you are making at the top of the page Mr K.
There is cash burn and no progress. The business model isnt working and they need a kick up their backsides.
The statement yesterday stated that they would not look to hand cash back but look for a possible takeover.
Your point about jobs is invalid though. Companies should not just exist to burn cash paying employees and directors. If it is the view of the shareholders that no value exists within the business or this is the case then good luck to the shareholders who want to take this course of action. The shoe is normally on the other foot.

I do not hold a position in this stock.

[day_dreamer] 12/12/2002 16:22

From agressive saver to london trader to responsible lad :-))

LOL !!!

Gravy

[responsible lad] 12/12/2002 16:04

Even if it does fail, 15p is still my price target since a takeover bid will come or one of their products will come up trumphs. A strong buy @6.25p, I paid 6p last week and I am very happy with how my purchase has done, compared to most shares that are falling fast every day.

Kind Regards
RL

[pdyke14856] 11/12/2002 18:11

Dolly the Sheep creator PPL fires back at critics


Wed 11 Dec 2002(108594)

LONDON (ShareCast) - PPL Therapeutics, who helped create Dolly the sheep, attacked shareholders who are trying to force the company to sell up or return cash to shareholders as misguided
The Scottish firm, where the share price has tumbled since the start of the year, has come under attack from investors led by activist Paul Scott, who, it is reported has over 11% stake in the pharmaceutical company.

In defence of PPL, Chief Executive Geoff Cook said the move was not in shareholders' best interests. He added that he was open to takeover approaches although it was perhaps unrealistic to expect big player to buy the business.

Cook, it was reported, also said he hoped to sell PPL's pig organ business early next year which would produce some cash. The company's scientists have developed piglets whose organs could be used in human operations.

[marktw] 10/12/2002 09:25

why the drop?

[bigbadgar] 09/12/2002 17:12

its going well paul, keep it going!
woo
G

[eugene1234] 09/12/2002 08:58

would someone kindly let me know how level 2 is looking - thanks
eugene

[crystalclear] 08/12/2002 09:48

Drsmessguide
I'll have to trust most of what you say, but it looks right and I assume most posters are right until I detect anything deliberately wrong in what they post. The reason I say I'll have to trus it is ignorance on my part: I am not familiar with all the medical stuff.

It does seem that an immediate sale of the transgenics would be the best solution in the short term. I guess one problem is any potential buyer could just be waiting for the situation to get worse for PPL.

The situation with AAT, as I see it, is production cost. Current treatments are ridiculously expensive, hence Bayer are prepared to join forces with PPL to have a cheaper supply, rather than compete against us, despite them already having the market.

If I were not a PPL shareholder, I would call that a monopoly.

If the other drugs are good enough to get us to market with AAT, then that is okay. If we can sell the transplant stuff to get cash to get the other drugs t market then that is good too.

If there are problems with the previous solution then I have no objection to cutting and running. I am not really in profit on PPL, but I'm not really in loss either. I rode a wave from £1 to about £2.60 some time back, well before the recent dilution and think there is more money to be made by keeping the company IF we can get AAT to market.

That is my chief objection to Pauly's tactics which on the face of it seem to be slightly too hard line, although I don't know if this is his real stance, or a tactic to get the company to pay attention.

[drsmessguide] 08/12/2002 08:20

Adapted from my post on the 'savedollythesheep' website;

With regard to the products they're persuing; It seems the fibrin product is not likely to be a huge earner as there are existing products on the market. I watched a small cap pharma soar on news that it was to launch a new ACE inhibitor, with at least 6 on the market its going to flop. 'Me too' medical drugs dont work, the first player captures the market and only if number 2 or 3 are from big pharma who can out market the earlier drug, or if the second drug has a major advantage will it get a significant foot hold.
Prime example is Zantac, the drug that built Glaxo. First mover was Tagamet, it captured a sizeable market but was quickly followed by Zantac, more potent and well marketed, there were several'Me toos' but none made any significant money and Zantac became a huge blockbuster.
The Lipase drug is also I think unlikely to displace Creon which is well established and safe. The trials seem to indicate that the Lipase is, at best as good as Creon but its sure to be more expensive. The suggestion that compliance is a problem with Creon doesnt wash. Creon is taken to relieve symptoms of bloating wind and smelly farts and motions, apart from on a boys night out, Id think youd take your pills, am i right?

The company rests on the Alpha Antitrypsin preparation which, if it works could help most emphysemics and those with CF. There are a specific group of sufferers who have AAT dificiency and develop early emphysema but most emphysemics have a relative deficiency caused by carrying half of the abnormal genes so one would imagine they too would benefit. I havnt though seen the evidence for it improving symptoms or prognosis in sufferers. So a potential blockbuster but may come to naught.

Any value I think lies in its patents and the latter drug. A sale of the transgenics department would be a welcome boost to the cash bank. There was talk of 'several' possible buyers and a sale by the end of 2002, thats 3 weeks boys!

[crystalclear] 07/12/2002 15:25

But if it can survive, I hope we go for production and not closure!
(Not meant to be an inflamatory remark PROPANE!)

[propane] 07/12/2002 15:03

Shareholders of biotech PPL Therapeutics are planning an uprising. A group of disgruntled investors have joined forced in an attempt to get PPL to return cash to them, unless it can prove it can survive. The shareholder action group now holds an 11% stake in the firm, which makes them a majority holder, with enough clout to force an emergency general meeting. Things could get 'interesting' concludes The Guardian.

[dell314] 07/12/2002 00:55

From ADVFN lunchtime newsletter -"PPL Therapeutics added 1-1/2 to 6-3/4 on talk that activist investor Paul Scott is continuing to stake-build".

[goldrush] 06/12/2002 14:37

Now joined the Action Group & decided to buy more.If this shareholding keeps increasing at this rate a total cash distribution of at least 15p lokks an odds on certainty IMHO.

g

[vinyy] 06/12/2002 14:22

FT falling, methinks this stock should do well (sector jumping) mehopes.

[mykai] 06/12/2002 11:12

mm s still short of shares hang on the bid should go up all day steady as she goes

[vinyy] 06/12/2002 11:07

Bid up, guess what mms want your shares, 10p please.

[chicogabb] 06/12/2002 11:03

perhaps these guys should merge with BBG, get adouble wammy........

[vinyy] 06/12/2002 11:00

200k delayed buy woooossssh, oh yes

[the ignorance] 06/12/2002 10:59

Any ideas on target price now?

[london trader] 06/12/2002 10:09

I was just thinking about getting more at 6.5p and now they gone up to 7p, doh. Still pleased to be in profit from this morning.

[marktw] 06/12/2002 09:58

Why wouldn't the big investment houses want to play ball? Surely their money will go done the swannee like every other shareholder if we allow the current situation to continue? What reasoning would they have for not supporting such an action?